Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II StudyReiki Nishimura, Kazuo Tamura, Takahiro Ogawa et al.|Chemotherapy|2005Cited by 13
Dose Escalation Study of Epirubicin and Docetaxel in Patients with Advanced or Recurrent Breast CancerIchiro Ichinose, Kazuo Tamura, N Horikoshi et al.|Chemotherapy|2008Cited by 6
Immunocytochemical study on the variation in estrogen receptors of primary and nodal metastases of breast cancerMasakazu Toi, Takao Hattori, Minoru Niimoto et al.|Surgery Today|1988Cited by 4